4-羟基-3-甲基-2-丁酮 | 3393-64-4

• 物质功能分类: 化学试剂 - 有机试剂 - 脂肪醇
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-羟基-3-甲基-2-丁酮
• 英文名称: 4-hydroxy-3-methyl-2-butanone
• 英文别名: 4-hydroxy-3-methylbutan-2-one
• CAS: 3393-64-4
• 化学式: C₅H₁₀O₂
• mdl: MFCD00004739
• 分子量: 102.133
• InChiKey: VVSRECWZBBJOTG-UHFFFAOYSA-N

物化性质

• 熔点：
  2.5°C (estimate)
• 沸点：
  90-95 °C/15 mmHg(lit.)
• 密度：
  0.993 g/mL at 25 °C(lit.)
• 闪点：
  79 °C
• LogP：
  -0.440 (est)
• 保留指数：
  826;832
• 稳定性/保质期：
  在常温常压下保持稳定。

计算性质

• 辛醇/水分配系数(LogP)：
  -0.2
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2914400090
• 安全说明：
  S24/25
• 储存条件：
  常温、避光、通风干燥处，密封保存。

SDS

Name:	4-Hydroxy-3-methyl-2-butanone tech. ca. 85% Material Safety Data Sheet
Synonym:	4-Hydroxy-3-methylbutan-2-on
CAS:	3393-64-4

Section 1 - Chemical Product MSDS Name:4-Hydroxy-3-methyl-2-butanone tech. ca. 85% Material Safety Data Sheet
Synonym:4-Hydroxy-3-methylbutan-2-on

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
3393-64-4	4-Hydroxy-3-methyl-2-butanone, tech.	85	222-238-6

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and corneal damage.
Skin:
May cause irritation and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Aspiration may lead to pulmonary edema. Inhalation at high concentrations may cause CNS depression and asphixiation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Combustible liquid.
Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Remove all sources of ignition. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust. Use a spark-proof tool. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use only in a well-ventilated area. Avoid contact with eyes, skin, and clothing. Empty containers retain product residue, (liquid and/or vapor), and can be dangerous. Keep container tightly closed. Keep away from heat, sparks and flame. Avoid ingestion and inhalation. Do not pressurize, cut, weld, braze, solder, drill, grind, or expose empty containers to heat, sparks or open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local explosion-proof ventilation to keep airborne levels to acceptable levels.
Exposure Limits CAS# 3393-64-4: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Clear liquid
Color: clear, colorless
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 90.0 - 95.0 deg C @ 15.00mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: 78 deg C ( 172.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water: Not available.
Specific Gravity/Density: .9930g/cm3
Molecular Formula: C5H10O2
Molecular Weight: 102.13

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases, reducing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 3393-64-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Hydroxy-3-methyl-2-butanone, tech. - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 3393-64-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 3393-64-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 3393-64-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-羟基-3-甲基-2-丁酮 在 磷酸 、 phosphorus pentoxide 、 铜 、 对苯二酚 作用下， 以69%的产率得到2-甲基-1-丁烯-3-酮
  参考文献：
  名称：

  全反式无环类异戊二烯信息素成分的合成

  摘要：

  全反式无环类异戊二烯骨架是通过两步迭代序列制成的。该方法涉及由烯丙基醇形成的烯丙基乙烯基醚的克莱森重排和甲基异丙烯基酮的二甲基乙缩醛，然后通过重排形成的LiAlH 4还原α，β-不饱和酮。通过使用一锅脱氧反应来合成（E） -β-法呢烯，（E） -β-弹簧烯和树突蛋白，α，β-不饱和酮也被转化为2-甲基-1-丙烯基。

  DOI：

  10.1016/s0040-4020(01)86580-7
• 作为产物：
  描述：

  2-甲基-1-丁烯-3-酮 在 硫酸 作用下， 生成 4-羟基-3-甲基-2-丁酮
  参考文献：
  名称：

  508. 2-甲基丁-2-烯亚硝基氯化物及其衍生物

  摘要：

  DOI：

  10.1039/jr9560002587

文献信息

• Erbium(III) Triflate as an Extremely Active Acylation Catalyst
  作者：Antonio Procopio、Renato Dalpozzo、Antonio De?Nino、Loredana Maiuolo、Beatrice Russo、Giovanni Sindona

  DOI：10.1002/adsc.200404132

  日期：2004.10

  Erbium(III) triflate is a powerful catalyst for the acylation of alcohols and phenols. The reaction works well for a large variety of simple and functionalized substrates by using different kinds of acidic anhydrides Ac2O, (EtCO)2O, [(CH3)3CO]2O, Bz2O, and (CF3CO)2O} without isomerisation of chiral centres. Moreover, the catalyst can be easily recycled and reused without significant loss of activity

  三氟甲磺酸（（III）是醇和苯酚酰化的有力催化剂。通过使用不同种类的酸酐Ac 2 O，（EtCO）2 O，[（CH 3）3 CO] 2 O，Bz 2 O，和（CF 3 CO）2 O}，而没有手性中心的异构化。而且，该催化剂可以容易地再循环和再利用而没有明显的活性损失。
• [EN] DITHIOLAN-3-YLPENTANOATE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN<br/>[FR] DÉRIVÉS DE DITHIOLAN-3-YLPENTANOATE, COMPOSITIONS PHARMACEUTIQUES ET MÉTHODES DE TRAITEMENT DE LA DOULEUR
  申请人：KRISANI BIOSCIENCES P LTD

  公开号：WO2015118554A1

  公开（公告）日：2015-08-13

  The disclosure herein provides 1-carbamoyloxyethyl 5-(1,2-dithiolan-3-yl)pentanoate derivatives of formula I, formula II and formula III. The disclosure also provides a method of synthesizing the compound of formula I, formula II and formula III. The compound of formula I, formula II and formula III or its pharmaceutical acceptable salts, as well as polymorphs, solvates, and hydrates, thereof may be formulated as pharmaceutical composition. The pharmaceutical composition of compound of formula I, formula II and formula III or the final compound of formula I, formula II or formula III may be formulated for non-invasive peroral, topical (example transdermal), enteral, transmucosal, targeted delivery, sustained release delivery, delayed release, pulsed release and parenteral methods. Such compositions may be used to treat chronic pain manifested with chronic diseases or its associated complications.

  本公开提供了式I、式II和式III的1-羰胺氧乙基5-(1,2-二硫代环戊烷-3-基)戊酸酯衍生物。本公开还提供了一种合成式I、式II和式III化合物的方法。式I、式II和式III化合物或其药用可接受的盐，以及其多晶型、溶剂合物和水合物，可制成药物组合物。式I、式II和式III化合物的药物组合物或式I、式II或式III的最终化合物可制成用于非侵入性口服、局部（例如经皮）、肠内、经粘膜、靶向递送、持续释放递送、延迟释放、脉冲释放和静脉途径的方法。这种组合物可用于治疗伴随慢性疾病或其相关并发症表现的慢性疼痛。
• Erbium(III) Chloride: a Very Active Acylation Catalyst
  作者：Renato Dalpozzo、Antonio De Nino、Loredana Maiuolo、Manuela Oliverio、Antonio Procopio、Beatrice Russo、Amedeo Tocci

  DOI：10.1071/ch06346

  日期：——

  Erbium(iii) chloride is a powerful catalyst for the acylation of alcohols and phenols. The reaction works well for a large variety of simple and functionalized substrates by using different kinds of acidic anhydrides (Ac2O, (EtCO)2O, (PriCO)2O, (ButCO)2O, and (CF3CO)2), without isomerization of chiral centres. Moreover, the catalyst can be easily recycled and reused without significant loss of activity

  氯化铒（iii）是醇和酚酰化的强效催化剂。通过使用不同种类的酸酐（Ac2O、(EtCO)2O、(PriCO)2O、(ButCO)2O 和 (CF3CO)2），该反应适用于多种简单和功能化的底物，且没有手性中心的异构化. 此外，催化剂可以很容易地回收和再利用，而不会显着降低活性。
• Metal-Catalyzed Rearrangement of Homoallylic Ethers to Silylmethyl Allylic Silanes in the Presence of a Di-<i>tert</i>-butylsilylene Source
  作者：Pamela A. Cleary、K. A. Woerpel

  DOI：10.1021/ol052456x

  日期：2005.11.1

  transfer to gem-disubstituted alkenes to form silacyclopropanes, we discovered an unprecedented reaction of homoallylic ethers. When silylene transfer was performed at room temperature or above, two di-tert-butylsilylene units were incorporated into the molecule, and complete rearrangement of the carbon backbone occurred. This report describes the scope of this unique reaction as well as the mechanistic

  [反应：见正文]在研究将二叔丁基亚甲硅烷基转移到宝石二取代的烯烃以形成硅环丙烷的范围时，我们发现了均空醚的空前反应。当在室温或更高温度下进行亚甲硅烷基转移时，两个二叔丁基亚甲硅烷基单元被引入分子中，并且碳主链发生了完全重排。该报告描述了这种独特反应的范围以及进行了机制研究的机制。
• POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND PHOTORESIST COMPOSITION
  申请人：JNC CORPORATION

  公开号：US20210009546A1

  公开（公告）日：2021-01-14

  A polymerizable compound represented by formula (1). In formula (1), one of eight hydrogen atoms is substituted by a (meth)acryloyloxy group, and the rest seven hydrogen atoms are independently non-substituted or substituted by a saturated hydrocarbon group having 1 to 10 carbons.

  公式（1）所代表的可聚合化合物。在公式（1）中，八个氢原子中的一个被（甲基）丙烯酰氧基取代，其余七个氢原子独立地未被取代或被具有1至10个碳原子的饱和碳氢基团取代。

表征谱图